Dr Matthew Joseph Boren, DO in Aberdeen Proving Ground, MD - Medicare

Dr Matthew Joseph Boren, DO is a medicare enrolled "Emergency Medicine" physician in Aberdeen Proving Ground, Maryland. His current practice location is 2501 Oakington St, Aberdeen Proving Ground, Maryland. You can reach out to his office (for appointments etc.) via phone at (410) 278-1967.

Dr Matthew Joseph Boren is licensed to practice in California (license number 20A11375) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1801939384.

Contact Information

	Dr Matthew Joseph Boren, DO
	2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131
	(410) 278-1967
	(410) 278-1957

Physician's Profile

Full Name	Dr Matthew Joseph Boren
Gender	Male
Speciality
Experience	Years
Location	2501 Oakington St, Aberdeen Proving Ground, Maryland
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Matthew Joseph Boren attended and graduated from in

NPI Data:

NPI Number: 1801939384
Provider Enumeration Date: 02/15/2007
Last Update Date: 01/26/2023

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Matthew Joseph Boren such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1801939384	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	H0065579 (Maryland)	Secondary
207P00000X	Emergency Medicine	20A11375 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Matthew Joseph Boren is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Matthew Joseph Boren, DO 2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131 Ph: (410) 278-1967	Dr Matthew Joseph Boren, DO 2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131 Ph: (410) 278-1967

News Archive

NSU faculty and students provide schoolchildren with hearing aids in BVI

Students and faculty from Nova Southeastern University recently completed their second medical mission in the British Virgin Islands (BVI), where they provided schoolchildren with hearing aids and audiology services.

People who get easily bored or frustrated are prone to body-focused repetitive behaviors

Individuals who get easily bored, frustrated or impatient are more inclined to develop skin-picking and other body-focused repetitive behaviors, say researchers at the Institut universitaire en santé mentale de Montréal and the University of Montreal.

WuXi NextCODE, CHFU partner to advance precision medicine in China

WuXi NextCODE, a precision medicine company using the genome to improve health worldwide, and the Children's Hospital of Fudan University, based in Shanghai and serving 2.3 million patients nationwide per year, today announced the signing of a landmark agreement for advancing precision medicine in China.

Salivary IL-6 could predict recurrence after surgery in mouth cancer patients

Salivary levels of the proinflammatory cytokine interleukin-6 could be a useful predictor for locoregional recurrence in oral squamous cell carcinoma patients who are treated surgically, report researchers.

Involvement of nicotine receptors in COVID-19

Researchers from the University of Bristol, Oxford Brookes University and the University of California San Diego neatly demonstrated how the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits high affinity for nicotinic acetylcholine receptors (nAChRs), with significant implications for coronavirus disease (COVID-19) pathology and infectivity. Their findings are published on the bioRxiv* preprint server.

Dr Matthew Joseph Boren, DO - Medicare in Aberdeen Proving Ground, MD